isoniazid glutathione Mitochondrial injury and depletion in HepG2 cells treated and quality Isoniazid (PIM 288)
Description
There is evidence to suggest that PPA are formed in healthy individuals at therapeutic doses, particularly following repeated doses, suggesting that not all NAPQI is scavenged by glutathione even during therapeutic administration (see Fig
In the intermediate stage, visual abnormalities may begin to appear, with some patients remaining asymptomatic while others show signs of blurry and distorted vision [21, 22]
In addition to restoring the balance of microbial community in the intestine, it provides a mean to replenish the microbial community with SCFA producers to fortify the intestinal barrier
PMID 19549913
